Abstract:Bone Morphogenetic Proteins (BMPs) and other members of TGFβ superfamily regulate cell growth and differentiation. Abrogation of cellular responses to BMP/TGFβ is associated with human diseases such as cancer, cardiovascular, autoimmune and skeletal diseases. One of the most critical events in activation of BMP signal transduction pathway is the phosphorylation of transcription factor Smad1/5/8 (collective term for Smad1, Smad5 and Smad8) by BMP receptors. While phosphorylated Smad1/5/8 directly activate the BMP-induced gene transcription in the nucleus, protein phosphatases are anticipated to dephosphorylate phospho-Smad1/5/8 and consequently terminate BMP signaling. The identity of the long sought-after phosphatase has been one of the major unanswered questions in BMP/TGFβ biology. Objective: (1) To characterize how PPM1H physically interacts with and functionally dephosphorylate BMP-specific Smads, and (2) to investigate the functions of PPM1H in BMP-induced gene expression and osteoblast differentiation. Methods: We first built a library consisting of the entire set of protein phosphatases encoded by the human genome and then undertook a genome-wide screen for Smad phosphatases. BMP-induced Smad phosphorylation was analyzed using immunological methods such as immunoprecipitation, western blotting and immunofluorescence. Effects of PPM1H overexpression and knockdown on the level of Smad phosphorylation were determined by anti-phospho-Smad1 Western blotting. Real-time PCR, transcriptional analyses of BMP target genes and alkaline phosphatase assays were carried out to determine the functions of PPM1H in regulating BMP responses and osteoblast differentiation. Results: To identify the Smad phosphatases, we first built a library consisting of the entire set of protein phosphatases encoded by the human genome and then undertook a genome-wide screen. By using combined methods of functional genomics and biochemistry, we discovered that PPM1H represents a novel cytoplasm-localized Smad1/5/8-specific phosphatase. The effects of PPM1H on controlling the level of phosphorylated Smad1/5/8 (P-Smad1/5/8) were analyzed by immunological methods, e.g. immunofluorescence and western blotting, using a phospho-specific antibody against P-Smad1/5/8. PPM1H clearly dephosphorylated P-Smad1/5/8 in vivo and in vitro. In vitro binding, immunoprecipitation, and bimolecular fluorescence complementation assays demonstrated that PPM1H and Smad1 directly interact with each other in the cytoplasm. Consequently, ectopic expression of PPM1H in cells abolished BMP-induced gene expression as measured by real-time PCR and transcriptional reporter assays, and loss of PPM1H activity (site mutagenesis) or expression (RNA interference) greatly enhanced BMP signaling and osteoblast differentiation. Conclusion: PPM1H acts as a gatekeeper to prevent excessive BMP signal transduction through dephosphorylation and subsequent nuclear exclusion of Smad1/5/8. Our results not only gain insights into the important role of BMP signaling in human growth and development, but also are pertinent towards novel therapeutic approaches for the prevention and treatment of human diseases.

Identification and Functional Characterization of Distinct Critically Important Bone Morphogenetic Protein-specific Response Elements in the Id1 Promoter*

Tgf-Beta and Bmp Signaling in Osteoblast, Skeletal Development, and Bone Formation, Homeostasis and Disease

Controlling Cell Fate By Bone Morphogenetic Protein Receptors

Inhibitor of DNA Binding/Differentiation Helix-Loop-Helix Proteins Mediate Bone Morphogenetic Protein-induced Osteoblast Differentiation of Mesenchymal Stem Cells

Stimulation of Id1 Expression by Bone Morphogenetic Protein is Sufficient and Necessary for Bone Morphogenetic Protein–Induced Activation of Endothelial Cells

Identification and Functional Characterization of a Smad Binding Element (SBE) in the JunB Promoter That Acts As a Transforming Growth Factor-β, Activin, and Bone Morphogenetic Protein-inducible Enhancer

Smad1 Interacts with Homeobox DNA-binding Proteins in Bone Morphogenetic Protein Signaling

Gene array analysis of bone morphogenetic protein type I receptor-induced osteoblast differentiation.

[The Role of Smads and Related Transcription Factors in the Signal Transduction of Bone Morphogenetic Protein Inducing Bone Formation].

The L45 Loop in Type I Receptors for Tgf-Beta Family Members is A Critical Determinant in Specifying Smad Isoform Activation

Specific control of BMP signaling and mesenchymal differentiation by cytoplasmic phosphatase PPM1H

Cross-talk between Wnt and bone morphogenetic protein 2 (BMP-2) signaling in differentiation pathway of C2C12 myoblasts

Activation of c-Jun NH2-terminal kinase 1 increases cellular responsiveness to BMP-2 and decreases binding of inhibitory Smad6 to the type 1 BMP receptor

Bone Morphogenetic Protein Signalling in Ngf-Stimulated Pc12 Cells

Participation of Smad2, Smad3, and Smad4 in Transforming Growth Factor β (TGF-β)-induced Activation of Smad7

Smad Signaling in Mesenchymal and Chondroprogenitor Cells

A phylogenetically conserved cis-regulatory module in the Msx2 promoter is sufficient for BMP-dependent transcription in murine and Drosophila embryos

Transforming Growth Factor Beta Can Stimulate Smad1 Phosphorylation Independently of Bone Morphogenic Protein Receptors

Novel Phosphatase PPM1H Controls BMP Signaling and Osteoblast Differentiation

Smad6 Recruits Transcription Corepressor CtBP to Repress Bone Morphogenetic Protein-Induced Transcription.

Efficient TGF-beta induction of the Smad7 gene requires cooperation between AP-1, Sp1, and Smad proteins on the mouse Smad7 promoter.